The Clonidine Hydrochloride Tablets, cataloged under National Stock Number 6505-01-101-3729, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Danbury Pharmacal Inc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-101-3729 |
| Primary Part Number | NDC00591-5613-01 |
| Item Name | Clonidine Hydrochloride Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Danbury Pharmacal Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 0.300 MILLIGRAMS CLONIDINE HYDROCHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00591-5613-01 PRIMARY | Danbury Pharmacal Inc (USA) |
| NDC00597-0011-01 | Boehringer Ingelheim Pharmaceuticals Inc (USA) |
| NDC00378-0199-01 PRIMARY | Mylan Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00781-1473-01 | 5/9 Secondary reference Geneva Pharmaceuticals Inc |
| CATAPRES | 5/1 Secondary reference Boehringer Ingelheim Pharmaceuticals Inc |
NSN 6505-01-101-3729 is a Clonidine Hydrochloride Tablets, manufactured by Danbury Pharmacal Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-101-3729 has 3 manufacturer part numbers on file: NDC00591-5613-01 (Danbury Pharmacal Inc), NDC00597-0011-01 (Boehringer Ingelheim Pharmaceuticals Inc), NDC00378-0199-01 (Mylan Pharmaceuticals Inc).
Key specifications for NDC00591-5613-01: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: EQUIVALENT TO 0.261 MG CLONIDINE PER TABLET. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.